Proliferative vitreoretinopathy - developments in adjunctive treatment and retinal pathology

被引:148
作者
Charteris, DG
Sethi, CS
Lewis, GP
Fisher, SK
机构
[1] Moorfields Eye Hosp, Vitreoretinal Res Unit, NHS Trust, London EC1V 2PD, England
[2] Inst Ophthalmol, London EC1V 9EL, England
[3] Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA
关键词
retinal detachment; proliferative vitreoretinopathy; retinal plasticity;
D O I
10.1038/sj.eye.6700194
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Proliferative vitreoretinopathy (PVR) remains a difficult management problem despite advances in vitreoretinal surgery. There is still a significant incidence of PVR in rhegmatogenous retinal detachment and other forms of retinal disease. Surgery for PVR now has a high anatomical success rate although visual results are often disappointing. The use of adjunctive treatments to prevent cellular proliferation holds promise for the prevention of PVR or recurrences after surgery. Control of proliferation and strategies aimed at improving visual outcome are important areas of future research in PVR and other forms of retinal disease. Studies of the intraretinal and peri-retinal pathology of PVR have demonstrated characteristic changes which may have a significant influence on visual outcome and surgical management.
引用
收藏
页码:369 / 374
页数:6
相关论文
共 44 条
  • [1] SOPHISTICATED VITREORETINAL SURGERY IN PATIENTS WITH A HEALTHY FELLOW EYE - AN 11-YEAR RETROSPECTIVE STUDY
    ANDENMATTEN, R
    GONVERS, M
    [J]. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 1993, 231 (09) : 495 - 499
  • [2] How to predict proliferative vitreoretinopathy - A prospective study
    Asaria, RHY
    Kon, CH
    Bunce, C
    Charteris, DG
    Wong, D
    Luthert, P
    Khaw, PT
    Aylward, GW
    [J]. OPHTHALMOLOGY, 2001, 108 (07) : 1184 - 1186
  • [3] Adjuvant 5-fluorouracil and heparin prevents proliferative vitreoretinopathy - Results from a randomized, double-blind, controlled clinical trial
    Asaria, RHY
    Kon, CH
    Bunce, C
    Charteris, DG
    Wong, D
    Khaw, PT
    Aylward, GW
    [J]. OPHTHALMOLOGY, 2001, 108 (07) : 1179 - 1183
  • [4] AZEN SP, 1992, ARCH OPHTHALMOL-CHIC, V110, P770
  • [5] AZEN SP, 1992, ARCH OPHTHALMOL-CHIC, V110, P780
  • [6] Cryopexy in primary rhegmatogenous retinal detachment: A risk factor for postoperative proliferative vitreoretinopathy?
    Bonnet, M
    Fleury, J
    Guenoun, S
    Yaniali, A
    Dumas, C
    Hajjar, C
    [J]. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 1996, 234 (12) : 739 - 743
  • [7] Pathogenic mechanisms in proliferative vitreoretinopathy
    Campochiaro, PA
    [J]. ARCHIVES OF OPHTHALMOLOGY, 1997, 115 (02) : 237 - 241
  • [8] Post traumatic proliferative vitreoretinopathy - The epidemiologic profile, onset, risk factors, and visual outcome
    Cardillo, JA
    Stout, JT
    LaBree, L
    Azen, SP
    Omphroy, L
    Cui, JZ
    Kimura, H
    Hinton, DR
    Ryan, SJ
    [J]. OPHTHALMOLOGY, 1997, 104 (07) : 1166 - 1173
  • [9] GIANT RETINAL TEARS - SURGICAL TECHNIQUES AND RESULTS USING PERFLUOROCARBON LIQUIDS
    CHANG, S
    LINCOFF, H
    ZIMMERMAN, NJ
    FUCHS, W
    [J]. ARCHIVES OF OPHTHALMOLOGY, 1989, 107 (05) : 761 - 766
  • [10] CHANG S, 1994, MED SURG RETINA, P199